SCHEMBL17875965

SCHEMBL17875965

O=S1(=O)Cc2cc(-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)ccc2-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.51
CYP11B1 P15538 12/20 0.44
CYP11B2 P19099 12/20 0.44
CYP1A2 P05177 6/20 0.44
TDP2 O95551 2/20 0.44
DHODH Q02127 1/20 0.42
CYP2C9 P11712 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
PDK2 Q15119 2/20 0.41
CYP17A1 P05093 2/20 0.39
KDM1A O60341 1/20 0.38
TBXAS1 P24557 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875974 1.00 CYP19A1 (0.51) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17876014 0.96 CYP19A1 (0.56) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17875957 0.92 TDP2 (0.51) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17875964 0.92 TDP2 (0.51) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17875969 0.91 CYP11B1 (0.52) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17875975 0.90 CYP19A1 (0.39) CYP19A1CYP1A2TDP2DHODHCYP2C19
SCHEMBL17875961 0.90 CYP19A1 (0.39) CYP19A1CYP1A2TDP2DHODHCYP2C19
SCHEMBL17875977 0.90 MEN1 (0.39) CYP19A1TDP2DHODHKDM4E
SCHEMBL17876010 0.87 TDP2 (0.52) CYP19A1CYP11B1CYP11B2CYP1A2TDP2
SCHEMBL17876012 0.86 TDP2 (0.52) CYP19A1CYP11B1CYP11B2CYP1A2TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP19A1 167/4885CYP11B1 938/4885CYP11B2 1374/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 167/4885CYP11B1 938/4885CYP11B2 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.